Improving T Cell Function in the Solid Tumor Microenvironment with Combination Immunotherapeutic Strategies and Polyfunction PSI™

Discover the Immunotherapy Funnel & PSI's Contribution for Accelerating Discovery & Development.

Unlock Resource

Download this free resource and gain access to our full resource library!

Unlock All Resources

We will always keep your personal information safe. Complete this form to get unlimited access to all of our web resources and join over 10,000 leading researchers who receive industry pioneers' backed data straight to their inbox. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy.

You may unsubscribe and update your email subscription at any time.

Predict Response: Immunotherapy & Single-Cell Proteomics Evolving Together

In recent years, chemo- and radiotherapies have been supplanted by therapeutics aimed at turning one’s immune system against disease. Cancer immunotherapies, in particular immune checkpoint blockade and combination therapies, have demonstrated remarkable success in treating multiple refractory cancers.

In this E-Book we discuss:

Addressing Challenges in Solid Tumors with IsoPlexis’ Single-Cell Proteomics and Polyfunctional Strength Index PSITM
Finding Critical, Correlative Differences using IsoPlexis’ Systems
Utilizing Polyfunction with Combination Immunotherapies to Stratify Patients: The Vision

IsoPlexis2019-11-16T10:30:02-05:00